Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Current Assets (2016 - 2025)

Bio-Techne has reported Current Assets over the past 17 years, most recently at $637.4 million for Q4 2025.

  • Quarterly results put Current Assets at $637.4 million for Q4 2025, changed 0.44% from a year ago — trailing twelve months through Dec 2025 was $637.4 million (changed 0.44% YoY), and the annual figure for FY2025 was $608.3 million, down 1.48%.
  • Current Assets for Q4 2025 was $637.4 million at Bio-Techne, up from $609.5 million in the prior quarter.
  • Over the last five years, Current Assets for TECH hit a ceiling of $648.6 million in Q3 2024 and a floor of $510.6 million in Q2 2021.
  • Median Current Assets over the past 5 years was $599.3 million (2022), compared with a mean of $594.8 million.
  • Biggest five-year swings in Current Assets: rose 18.6% in 2022 and later dropped 6.02% in 2025.
  • Bio-Techne's Current Assets stood at $590.2 million in 2021, then fell by 4.24% to $565.2 million in 2022, then increased by 4.5% to $590.6 million in 2023, then rose by 7.45% to $634.6 million in 2024, then rose by 0.44% to $637.4 million in 2025.
  • The last three reported values for Current Assets were $637.4 million (Q4 2025), $609.5 million (Q3 2025), and $608.3 million (Q2 2025) per Business Quant data.